[1] IATTA R, BATTISTA M, MIRAGLIOTTA G, et al. Blood culture procedures and diagnosis of Malassezia furfur bloodstream infections:Strength and weakness[J]. Med Mycol, 2018, 56(7):828-833. [2] BYRD A L, BELKAID Y, SEGRE J A.The human skin microbiome[J]. Nat Rev Microbiol, 2018, 16(3):143-155. [3] TAJIMA M, SUGITA T, NISHIKAWA A, et al. Molecular analysis of Malassezia microflora in seborrheic dermatitis patients:comparison with other diseases and healthy subjects[J]. J Invest Dermatol, 2008, 128(2):345-351. [4] NASH A K, AUCHTUNG T A, WONG M C, et al. The gut mycobiome of the human microbiome project healthy cohort[J]. Microbiome, 2017, 5(1):153. [5] SUHR M J, BANJARA N, HALLEN-ADAMS H E.Sequence-based methods for detecting and evaluating the human gut mycobiome[J]. Lett Appl Microbiol, 2016, 62(3):209-215. [6] HAMAD I, ABOU ABDALLAH R, RAVAUX I, et al. Metabarcoding analysis of eukaryotic microbiota in the gut of HIV-infected patients[J]. PLoS One, 2018, 13(1):e0191913. [7] LIGUORI G, LAMAS B, RICHARD M L, et al. Fungal dysbiosis in mucosa-associated microbiota of Crohn's disease patients[J]. J Crohns Colitis, 2016, 10(3):296-305. [8] FRYKMAN P K, NORDENSKJOLD A, KAWAGUCHI A, et al. Characterization of bacterial and fungal microbiome in children with hirschsprung disease with and without a history of enterocolitis:A multicenter study[J]. PLoS One, 2015, 10(4):e0124172. [9] ABDILLAH A,RANQUE S. Chronic diseases associated with Malassezia yeast[J]. J Fungi (Basel), 2021, 7(10):855. [10] HUFFNAGLE G B,NOVERR M C.The emerging world of the fungal microbiome[J]. Trends Microbiol, 2013, 21(7):334-341. [11] COKER O O, NAKATSU G, DAI R Z, et al. Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer[J]. Gut, 2019, 68(4):654-662. [12] GAITANIS G, MAGIATIS P, HANTSCHKE M, et al. The Malassezia genus in skin and systemic diseases[J]. Clin Microbiol Rev, 2012, 25(1):106-141. [13] NAGATA R, NAGANO H, OGISHIMA D, et al. Transmission of the major skin microbiota, Malassezia, from mother to neonate[J]. Pediatr Int, 2012, 54(3):350-355. [14] HAMAD I, SOKHNA C, RAOULT D, et al. Molecular detection of eukaryotes in a single human stool sample from Senegal[J]. PLoS One, 2012, 7(7):e40888. [15] SPATZ M,RICHARD M L.Overview of the potential role of Malassezia in gut health and disease[J]. Front Cell Infect Microbiol, 2020, 10:201.DOI:10.3389/fcimb.2020.00201. [16] CHEHOUD C, ALBENBERG L G, JUDGE C, et al. Fungal signature in the gut microbiota of pediatric patients with inflammatory bowel disease[J]. Inflamm Bowel Dis, 2015, 21(8):1948-1956. [17] LIMON J J, TANG J, LI D, et al. Malassezia is associated with Crohn's disease and exacerbates colitis in mouse models[J]. Cell Host Microbe, 2019, 25(3):377-388.e6. [18] KOH A Y, Murine models of Candida gastrointestinal colonization and dissemination[J]. Eukaryot Cell, 2013, 12(11):1416-1422. [19] WANG T,FAN C,YAO A,et al. The adaptor protein card9 protects against colon cancer by restricting mycobiota-mediated expansion of myeloid-derived suppressor cells[J]. Immunity, 2018, 49(3):504-514.e4. [20] MALIK A, SHARMA D, MALIREDDI R K S, et al. SYK-CARD9 signaling axis promotes gut fungi-mediated inflammasome activation to restrict colitis and colon cancer[J]. Immunity, 2018, 49(3):515-530.e5. [21] FURUE M, TAKAHARA M, NAKAHARA T, et al. Role of AhR/ARNT system in skin homeostasis[J]. Arch Dermatol Res, 2014, 306(9):769-779. [22] MAGIATIS P, PAPPAS P, GAITANIS G, et al. Malassezia yeasts produce a collection of exceptionally potent activators of the Ah (dioxin) receptor detected in diseased human skin[J]. J Invest Dermatol, 2013, 133(8):2023-2030. [23] BOTSCHUIJVER S, ROESELERS G, LEVIN E, et al. Intestinal fungal dysbiosis is associated with visceral hypersensitivity in patients with irritable bowel syndrome and rats[J]. Gastroenterology, 2017, 153(4):1026-1039. [24] GAO R, KONG C, LI H, et al. Dysbiosis signature of mycobiota in colon polyp and colorectal cancer[J]. Eur J Clin Microbiol Infect Dis, 2017, 36(12):2457-2468. [25] SOKOL H, LEDUCQ V, ASCHARD H, et al. Fungal microbiota dysbiosis in IBD[J]. Gut, 2017, 66(6):1039-1048. [26] AYKUT B, PUSHALKAR S, CHEN R, et al. The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL[J]. Nature, 2019, 574(7777):264-267. |